カテゴリー： Market Monitor Global, 世界, 医療/バイオ

ヒト臓器オンチップモデルのグローバル市場展望 2023年-2029年：多臓器モデル、単一臓器モデル、ヒト組織モデル

◆英語タイトル：Human Organs-on-Chips Model Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23DC13313）

◆商品コード：MMG23DC13313
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年12月（※2025年版があります。お問い合わせください。）
◆ページ数：111
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のヒト臓器オンチップモデル市場規模と予測を収録しています。・世界のヒト臓器オンチップモデル市場：売上、2018年-2023年、2024年-2029年
・世界のヒト臓器オンチップモデル市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のヒト臓器オンチップモデル市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「多臓器モデル」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

ヒト臓器オンチップモデルのグローバル主要企業は、Emulate、 Mimetas、 Cherry Biotech、 CN Bio Innovations、 Nortis、 TissUse、 BiomimX、 Altis Biosystems、 Ananda Devices、 Netri、 React4life、 SynVivo、 Draper Laboratory、 AlveoliX、 TNO、 Hesperos、 Abance Biotechnology、 Beijing Daxiang Biotechなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、ヒト臓器オンチップモデルのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のヒト臓器オンチップモデル市場：タイプ別、2018年-2023年、2024年-2029年
世界のヒト臓器オンチップモデル市場：タイプ別市場シェア、2022年
・多臓器モデル、単一臓器モデル、ヒト組織モデル

世界のヒト臓器オンチップモデル市場：用途別、2018年-2023年、2024年-2029年
世界のヒト臓器オンチップモデル市場：用途別市場シェア、2022年
・創薬、疾患モデル構築、個別化医療、その他

世界のヒト臓器オンチップモデル市場：地域・国別、2018年-2023年、2024年-2029年
世界のヒト臓器オンチップモデル市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるヒト臓器オンチップモデルのグローバル売上、2018年-2023年
・主要企業におけるヒト臓器オンチップモデルのグローバル売上シェア、2022年
・主要企業におけるヒト臓器オンチップモデルのグローバル販売量、2018年-2023年
・主要企業におけるヒト臓器オンチップモデルのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Emulate、 Mimetas、 Cherry Biotech、 CN Bio Innovations、 Nortis、 TissUse、 BiomimX、 Altis Biosystems、 Ananda Devices、 Netri、 React4life、 SynVivo、 Draper Laboratory、 AlveoliX、 TNO、 Hesperos、 Abance Biotechnology、 Beijing Daxiang Biotech

*************************************************************

・調査・分析レポートの概要
ヒト臓器オンチップモデル市場の定義
市場セグメント
世界のヒト臓器オンチップモデル市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のヒト臓器オンチップモデル市場規模
世界のヒト臓器オンチップモデル市場規模：2022年 VS 2029年
世界のヒト臓器オンチップモデル市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのヒト臓器オンチップモデルの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のヒト臓器オンチップモデル製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：多臓器モデル、単一臓器モデル、ヒト組織モデル
ヒト臓器オンチップモデルのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：創薬、疾患モデル構築、個別化医療、その他
ヒト臓器オンチップモデルの用途別グローバル売上・予測

・地域別市場分析
地域別ヒト臓器オンチップモデル市場規模 2022年と2029年
地域別ヒト臓器オンチップモデル売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Emulate、 Mimetas、 Cherry Biotech、 CN Bio Innovations、 Nortis、 TissUse、 BiomimX、 Altis Biosystems、 Ananda Devices、 Netri、 React4life、 SynVivo、 Draper Laboratory、 AlveoliX、 TNO、 Hesperos、 Abance Biotechnology、 Beijing Daxiang Biotech
...

This research report provides a comprehensive analysis of the Human Organs-on-Chips Model market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Human Organs-on-Chips Model market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Human Organs-on-Chips Model, challenges faced by the industry, and potential opportunities for market players.
The global Human Organs-on-Chips Model market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Human Organs-on-Chips Model market presents opportunities for various stakeholders, including Drug Development, Disease Modeling. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Human Organs-on-Chips Model market. Additionally, the growing consumer demand present avenues for market expansion.
The global Human Organs-on-Chips Model market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Human Organs-on-Chips Model market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Human Organs-on-Chips Model market.
Market Overview: The report provides a comprehensive overview of the Human Organs-on-Chips Model market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Multi Organ Model, Single Organ Model), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Human Organs-on-Chips Model market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Human Organs-on-Chips Model market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Human Organs-on-Chips Model market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Human Organs-on-Chips Model market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Human Organs-on-Chips Model market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Human Organs-on-Chips Model market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Human Organs-on-Chips Model, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Human Organs-on-Chips Model market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Human Organs-on-Chips Model market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Multi Organ Model
Single Organ Model
Human Tissue Model
Market segment by Application
Drug Development
Disease Modeling
Personalized Medicine
Others
Global Human Organs-on-Chips Model Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Emulate
Mimetas
Cherry Biotech
CN Bio Innovations
Nortis
TissUse
BiomimX
Altis Biosystems
Ananda Devices
Netri
React4life
SynVivo
Draper Laboratory
AlveoliX
TNO
Hesperos
Abance Biotechnology
Beijing Daxiang Biotech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Organs-on-Chips Model, market overview.
Chapter 2: Global Human Organs-on-Chips Model market size in revenue and volume.
Chapter 3: Detailed analysis of Human Organs-on-Chips Model manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Organs-on-Chips Model in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Organs-on-Chips Model capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Human Organs-on-Chips Model Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Organs-on-Chips Model Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Organs-on-Chips Model Overall Market Size
2.1 Global Human Organs-on-Chips Model Market Size: 2022 VS 2029
2.2 Global Human Organs-on-Chips Model Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Human Organs-on-Chips Model Sales: 2018-2029
3 Company Landscape
3.1 Top Human Organs-on-Chips Model Players in Global Market
3.2 Top Global Human Organs-on-Chips Model Companies Ranked by Revenue
3.3 Global Human Organs-on-Chips Model Revenue by Companies
3.4 Global Human Organs-on-Chips Model Sales by Companies
3.5 Global Human Organs-on-Chips Model Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Human Organs-on-Chips Model Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Human Organs-on-Chips Model Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Organs-on-Chips Model Players in Global Market
3.8.1 List of Global Tier 1 Human Organs-on-Chips Model Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Organs-on-Chips Model Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Human Organs-on-Chips Model Market Size Markets, 2022 & 2029
4.1.2 Multi Organ Model
4.1.3 Single Organ Model
4.1.4 Human Tissue Model
4.2 By Type – Global Human Organs-on-Chips Model Revenue & Forecasts
4.2.1 By Type – Global Human Organs-on-Chips Model Revenue, 2018-2023
4.2.2 By Type – Global Human Organs-on-Chips Model Revenue, 2024-2029
4.2.3 By Type – Global Human Organs-on-Chips Model Revenue Market Share, 2018-2029
4.3 By Type – Global Human Organs-on-Chips Model Sales & Forecasts
4.3.1 By Type – Global Human Organs-on-Chips Model Sales, 2018-2023
4.3.2 By Type – Global Human Organs-on-Chips Model Sales, 2024-2029
4.3.3 By Type – Global Human Organs-on-Chips Model Sales Market Share, 2018-2029
4.4 By Type – Global Human Organs-on-Chips Model Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Human Organs-on-Chips Model Market Size, 2022 & 2029
5.1.2 Drug Development
5.1.3 Disease Modeling
5.1.4 Personalized Medicine
5.1.5 Others
5.2 By Application – Global Human Organs-on-Chips Model Revenue & Forecasts
5.2.1 By Application – Global Human Organs-on-Chips Model Revenue, 2018-2023
5.2.2 By Application – Global Human Organs-on-Chips Model Revenue, 2024-2029
5.2.3 By Application – Global Human Organs-on-Chips Model Revenue Market Share, 2018-2029
5.3 By Application – Global Human Organs-on-Chips Model Sales & Forecasts
5.3.1 By Application – Global Human Organs-on-Chips Model Sales, 2018-2023
5.3.2 By Application – Global Human Organs-on-Chips Model Sales, 2024-2029
5.3.3 By Application – Global Human Organs-on-Chips Model Sales Market Share, 2018-2029
5.4 By Application – Global Human Organs-on-Chips Model Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Human Organs-on-Chips Model Market Size, 2022 & 2029
6.2 By Region – Global Human Organs-on-Chips Model Revenue & Forecasts
6.2.1 By Region – Global Human Organs-on-Chips Model Revenue, 2018-2023
6.2.2 By Region – Global Human Organs-on-Chips Model Revenue, 2024-2029
6.2.3 By Region – Global Human Organs-on-Chips Model Revenue Market Share, 2018-2029
6.3 By Region – Global Human Organs-on-Chips Model Sales & Forecasts
6.3.1 By Region – Global Human Organs-on-Chips Model Sales, 2018-2023
6.3.2 By Region – Global Human Organs-on-Chips Model Sales, 2024-2029
6.3.3 By Region – Global Human Organs-on-Chips Model Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Human Organs-on-Chips Model Revenue, 2018-2029
6.4.2 By Country – North America Human Organs-on-Chips Model Sales, 2018-2029
6.4.3 US Human Organs-on-Chips Model Market Size, 2018-2029
6.4.4 Canada Human Organs-on-Chips Model Market Size, 2018-2029
6.4.5 Mexico Human Organs-on-Chips Model Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Human Organs-on-Chips Model Revenue, 2018-2029
6.5.2 By Country – Europe Human Organs-on-Chips Model Sales, 2018-2029
6.5.3 Germany Human Organs-on-Chips Model Market Size, 2018-2029
6.5.4 France Human Organs-on-Chips Model Market Size, 2018-2029
6.5.5 U.K. Human Organs-on-Chips Model Market Size, 2018-2029
6.5.6 Italy Human Organs-on-Chips Model Market Size, 2018-2029
6.5.7 Russia Human Organs-on-Chips Model Market Size, 2018-2029
6.5.8 Nordic Countries Human Organs-on-Chips Model Market Size, 2018-2029
6.5.9 Benelux Human Organs-on-Chips Model Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Human Organs-on-Chips Model Revenue, 2018-2029
6.6.2 By Region – Asia Human Organs-on-Chips Model Sales, 2018-2029
6.6.3 China Human Organs-on-Chips Model Market Size, 2018-2029
6.6.4 Japan Human Organs-on-Chips Model Market Size, 2018-2029
6.6.5 South Korea Human Organs-on-Chips Model Market Size, 2018-2029
6.6.6 Southeast Asia Human Organs-on-Chips Model Market Size, 2018-2029
6.6.7 India Human Organs-on-Chips Model Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Human Organs-on-Chips Model Revenue, 2018-2029
6.7.2 By Country – South America Human Organs-on-Chips Model Sales, 2018-2029
6.7.3 Brazil Human Organs-on-Chips Model Market Size, 2018-2029
6.7.4 Argentina Human Organs-on-Chips Model Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Human Organs-on-Chips Model Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Human Organs-on-Chips Model Sales, 2018-2029
6.8.3 Turkey Human Organs-on-Chips Model Market Size, 2018-2029
6.8.4 Israel Human Organs-on-Chips Model Market Size, 2018-2029
6.8.5 Saudi Arabia Human Organs-on-Chips Model Market Size, 2018-2029
6.8.6 UAE Human Organs-on-Chips Model Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Emulate
7.1.1 Emulate Company Summary
7.1.2 Emulate Business Overview
7.1.3 Emulate Human Organs-on-Chips Model Major Product Offerings
7.1.4 Emulate Human Organs-on-Chips Model Sales and Revenue in Global (2018-2023)
7.1.5 Emulate Key News & Latest Developments
7.2 Mimetas
7.2.1 Mimetas Company Summary
7.2.2 Mimetas Business Overview
7.2.3 Mimetas Human Organs-on-Chips Model Major Product Offerings
7.2.4 Mimetas Human Organs-on-Chips Model Sales and Revenue in Global (2018-2023)
7.2.5 Mimetas Key News & Latest Developments
7.3 Cherry Biotech
7.3.1 Cherry Biotech Company Summary
7.3.2 Cherry Biotech Business Overview
7.3.3 Cherry Biotech Human Organs-on-Chips Model Major Product Offerings
7.3.4 Cherry Biotech Human Organs-on-Chips Model Sales and Revenue in Global (2018-2023)
7.3.5 Cherry Biotech Key News & Latest Developments
7.4 CN Bio Innovations
7.4.1 CN Bio Innovations Company Summary
7.4.2 CN Bio Innovations Business Overview
7.4.3 CN Bio Innovations Human Organs-on-Chips Model Major Product Offerings
7.4.4 CN Bio Innovations Human Organs-on-Chips Model Sales and Revenue in Global (2018-2023)
7.4.5 CN Bio Innovations Key News & Latest Developments
7.5 Nortis
7.5.1 Nortis Company Summary
7.5.2 Nortis Business Overview
7.5.3 Nortis Human Organs-on-Chips Model Major Product Offerings
7.5.4 Nortis Human Organs-on-Chips Model Sales and Revenue in Global (2018-2023)
7.5.5 Nortis Key News & Latest Developments
7.6 TissUse
7.6.1 TissUse Company Summary
7.6.2 TissUse Business Overview
7.6.3 TissUse Human Organs-on-Chips Model Major Product Offerings
7.6.4 TissUse Human Organs-on-Chips Model Sales and Revenue in Global (2018-2023)
7.6.5 TissUse Key News & Latest Developments
7.7 BiomimX
7.7.1 BiomimX Company Summary
7.7.2 BiomimX Business Overview
7.7.3 BiomimX Human Organs-on-Chips Model Major Product Offerings
7.7.4 BiomimX Human Organs-on-Chips Model Sales and Revenue in Global (2018-2023)
7.7.5 BiomimX Key News & Latest Developments
7.8 Altis Biosystems
7.8.1 Altis Biosystems Company Summary
7.8.2 Altis Biosystems Business Overview
7.8.3 Altis Biosystems Human Organs-on-Chips Model Major Product Offerings
7.8.4 Altis Biosystems Human Organs-on-Chips Model Sales and Revenue in Global (2018-2023)
7.8.5 Altis Biosystems Key News & Latest Developments
7.9 Ananda Devices
7.9.1 Ananda Devices Company Summary
7.9.2 Ananda Devices Business Overview
7.9.3 Ananda Devices Human Organs-on-Chips Model Major Product Offerings
7.9.4 Ananda Devices Human Organs-on-Chips Model Sales and Revenue in Global (2018-2023)
7.9.5 Ananda Devices Key News & Latest Developments
7.10 Netri
7.10.1 Netri Company Summary
7.10.2 Netri Business Overview
7.10.3 Netri Human Organs-on-Chips Model Major Product Offerings
7.10.4 Netri Human Organs-on-Chips Model Sales and Revenue in Global (2018-2023)
7.10.5 Netri Key News & Latest Developments
7.11 React4life
7.11.1 React4life Company Summary
7.11.2 React4life Business Overview
7.11.3 React4life Human Organs-on-Chips Model Major Product Offerings
7.11.4 React4life Human Organs-on-Chips Model Sales and Revenue in Global (2018-2023)
7.11.5 React4life Key News & Latest Developments
7.12 SynVivo
7.12.1 SynVivo Company Summary
7.12.2 SynVivo Business Overview
7.12.3 SynVivo Human Organs-on-Chips Model Major Product Offerings
7.12.4 SynVivo Human Organs-on-Chips Model Sales and Revenue in Global (2018-2023)
7.12.5 SynVivo Key News & Latest Developments
7.13 Draper Laboratory
7.13.1 Draper Laboratory Company Summary
7.13.2 Draper Laboratory Business Overview
7.13.3 Draper Laboratory Human Organs-on-Chips Model Major Product Offerings
7.13.4 Draper Laboratory Human Organs-on-Chips Model Sales and Revenue in Global (2018-2023)
7.13.5 Draper Laboratory Key News & Latest Developments
7.14 AlveoliX
7.14.1 AlveoliX Company Summary
7.14.2 AlveoliX Business Overview
7.14.3 AlveoliX Human Organs-on-Chips Model Major Product Offerings
7.14.4 AlveoliX Human Organs-on-Chips Model Sales and Revenue in Global (2018-2023)
7.14.5 AlveoliX Key News & Latest Developments
7.15 TNO
7.15.1 TNO Company Summary
7.15.2 TNO Business Overview
7.15.3 TNO Human Organs-on-Chips Model Major Product Offerings
7.15.4 TNO Human Organs-on-Chips Model Sales and Revenue in Global (2018-2023)
7.15.5 TNO Key News & Latest Developments
7.16 Hesperos
7.16.1 Hesperos Company Summary
7.16.2 Hesperos Business Overview
7.16.3 Hesperos Human Organs-on-Chips Model Major Product Offerings
7.16.4 Hesperos Human Organs-on-Chips Model Sales and Revenue in Global (2018-2023)
7.16.5 Hesperos Key News & Latest Developments
7.17 Abance Biotechnology
7.17.1 Abance Biotechnology Company Summary
7.17.2 Abance Biotechnology Business Overview
7.17.3 Abance Biotechnology Human Organs-on-Chips Model Major Product Offerings
7.17.4 Abance Biotechnology Human Organs-on-Chips Model Sales and Revenue in Global (2018-2023)
7.17.5 Abance Biotechnology Key News & Latest Developments
7.18 Beijing Daxiang Biotech
7.18.1 Beijing Daxiang Biotech Company Summary
7.18.2 Beijing Daxiang Biotech Business Overview
7.18.3 Beijing Daxiang Biotech Human Organs-on-Chips Model Major Product Offerings
7.18.4 Beijing Daxiang Biotech Human Organs-on-Chips Model Sales and Revenue in Global (2018-2023)
7.18.5 Beijing Daxiang Biotech Key News & Latest Developments
8 Global Human Organs-on-Chips Model Production Capacity, Analysis
8.1 Global Human Organs-on-Chips Model Production Capacity, 2018-2029
8.2 Human Organs-on-Chips Model Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Organs-on-Chips Model Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Organs-on-Chips Model Supply Chain Analysis
10.1 Human Organs-on-Chips Model Industry Value Chain
10.2 Human Organs-on-Chips Model Upstream Market
10.3 Human Organs-on-Chips Model Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Organs-on-Chips Model Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Human Organs-on-Chips Model in Global Market
Table 2. Top Human Organs-on-Chips Model Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Human Organs-on-Chips Model Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Human Organs-on-Chips Model Revenue Share by Companies, 2018-2023
Table 5. Global Human Organs-on-Chips Model Sales by Companies, (Units), 2018-2023
Table 6. Global Human Organs-on-Chips Model Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Human Organs-on-Chips Model Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Human Organs-on-Chips Model Product Type
Table 9. List of Global Tier 1 Human Organs-on-Chips Model Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Organs-on-Chips Model Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Human Organs-on-Chips Model Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Human Organs-on-Chips Model Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Human Organs-on-Chips Model Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Human Organs-on-Chips Model Sales (Units), 2018-2023
Table 15. By Type - Global Human Organs-on-Chips Model Sales (Units), 2024-2029
Table 16. By Application – Global Human Organs-on-Chips Model Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Human Organs-on-Chips Model Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Human Organs-on-Chips Model Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Human Organs-on-Chips Model Sales (Units), 2018-2023
Table 20. By Application - Global Human Organs-on-Chips Model Sales (Units), 2024-2029
Table 21. By Region – Global Human Organs-on-Chips Model Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Human Organs-on-Chips Model Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Human Organs-on-Chips Model Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Human Organs-on-Chips Model Sales (Units), 2018-2023
Table 25. By Region - Global Human Organs-on-Chips Model Sales (Units), 2024-2029
Table 26. By Country - North America Human Organs-on-Chips Model Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Human Organs-on-Chips Model Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Human Organs-on-Chips Model Sales, (Units), 2018-2023
Table 29. By Country - North America Human Organs-on-Chips Model Sales, (Units), 2024-2029
Table 30. By Country - Europe Human Organs-on-Chips Model Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Human Organs-on-Chips Model Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Human Organs-on-Chips Model Sales, (Units), 2018-2023
Table 33. By Country - Europe Human Organs-on-Chips Model Sales, (Units), 2024-2029
Table 34. By Region - Asia Human Organs-on-Chips Model Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Human Organs-on-Chips Model Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Human Organs-on-Chips Model Sales, (Units), 2018-2023
Table 37. By Region - Asia Human Organs-on-Chips Model Sales, (Units), 2024-2029
Table 38. By Country - South America Human Organs-on-Chips Model Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Human Organs-on-Chips Model Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Human Organs-on-Chips Model Sales, (Units), 2018-2023
Table 41. By Country - South America Human Organs-on-Chips Model Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Human Organs-on-Chips Model Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Human Organs-on-Chips Model Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Human Organs-on-Chips Model Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Human Organs-on-Chips Model Sales, (Units), 2024-2029
Table 46. Emulate Company Summary
Table 47. Emulate Human Organs-on-Chips Model Product Offerings
Table 48. Emulate Human Organs-on-Chips Model Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Emulate Key News & Latest Developments
Table 50. Mimetas Company Summary
Table 51. Mimetas Human Organs-on-Chips Model Product Offerings
Table 52. Mimetas Human Organs-on-Chips Model Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Mimetas Key News & Latest Developments
Table 54. Cherry Biotech Company Summary
Table 55. Cherry Biotech Human Organs-on-Chips Model Product Offerings
Table 56. Cherry Biotech Human Organs-on-Chips Model Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Cherry Biotech Key News & Latest Developments
Table 58. CN Bio Innovations Company Summary
Table 59. CN Bio Innovations Human Organs-on-Chips Model Product Offerings
Table 60. CN Bio Innovations Human Organs-on-Chips Model Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. CN Bio Innovations Key News & Latest Developments
Table 62. Nortis Company Summary
Table 63. Nortis Human Organs-on-Chips Model Product Offerings
Table 64. Nortis Human Organs-on-Chips Model Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Nortis Key News & Latest Developments
Table 66. TissUse Company Summary
Table 67. TissUse Human Organs-on-Chips Model Product Offerings
Table 68. TissUse Human Organs-on-Chips Model Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. TissUse Key News & Latest Developments
Table 70. BiomimX Company Summary
Table 71. BiomimX Human Organs-on-Chips Model Product Offerings
Table 72. BiomimX Human Organs-on-Chips Model Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. BiomimX Key News & Latest Developments
Table 74. Altis Biosystems Company Summary
Table 75. Altis Biosystems Human Organs-on-Chips Model Product Offerings
Table 76. Altis Biosystems Human Organs-on-Chips Model Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Altis Biosystems Key News & Latest Developments
Table 78. Ananda Devices Company Summary
Table 79. Ananda Devices Human Organs-on-Chips Model Product Offerings
Table 80. Ananda Devices Human Organs-on-Chips Model Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Ananda Devices Key News & Latest Developments
Table 82. Netri Company Summary
Table 83. Netri Human Organs-on-Chips Model Product Offerings
Table 84. Netri Human Organs-on-Chips Model Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Netri Key News & Latest Developments
Table 86. React4life Company Summary
Table 87. React4life Human Organs-on-Chips Model Product Offerings
Table 88. React4life Human Organs-on-Chips Model Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. React4life Key News & Latest Developments
Table 90. SynVivo Company Summary
Table 91. SynVivo Human Organs-on-Chips Model Product Offerings
Table 92. SynVivo Human Organs-on-Chips Model Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. SynVivo Key News & Latest Developments
Table 94. Draper Laboratory Company Summary
Table 95. Draper Laboratory Human Organs-on-Chips Model Product Offerings
Table 96. Draper Laboratory Human Organs-on-Chips Model Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Draper Laboratory Key News & Latest Developments
Table 98. AlveoliX Company Summary
Table 99. AlveoliX Human Organs-on-Chips Model Product Offerings
Table 100. AlveoliX Human Organs-on-Chips Model Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. AlveoliX Key News & Latest Developments
Table 102. TNO Company Summary
Table 103. TNO Human Organs-on-Chips Model Product Offerings
Table 104. TNO Human Organs-on-Chips Model Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. TNO Key News & Latest Developments
Table 106. Hesperos Company Summary
Table 107. Hesperos Human Organs-on-Chips Model Product Offerings
Table 108. Hesperos Human Organs-on-Chips Model Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Hesperos Key News & Latest Developments
Table 110. Abance Biotechnology Company Summary
Table 111. Abance Biotechnology Human Organs-on-Chips Model Product Offerings
Table 112. Abance Biotechnology Human Organs-on-Chips Model Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Abance Biotechnology Key News & Latest Developments
Table 114. Beijing Daxiang Biotech Company Summary
Table 115. Beijing Daxiang Biotech Human Organs-on-Chips Model Product Offerings
Table 116. Beijing Daxiang Biotech Human Organs-on-Chips Model Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 117. Beijing Daxiang Biotech Key News & Latest Developments
Table 118. Human Organs-on-Chips Model Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 119. Global Human Organs-on-Chips Model Capacity Market Share of Key Manufacturers, 2021-2023
Table 120. Global Human Organs-on-Chips Model Production by Region, 2018-2023 (Units)
Table 121. Global Human Organs-on-Chips Model Production by Region, 2024-2029 (Units)
Table 122. Human Organs-on-Chips Model Market Opportunities & Trends in Global Market
Table 123. Human Organs-on-Chips Model Market Drivers in Global Market
Table 124. Human Organs-on-Chips Model Market Restraints in Global Market
Table 125. Human Organs-on-Chips Model Raw Materials
Table 126. Human Organs-on-Chips Model Raw Materials Suppliers in Global Market
Table 127. Typical Human Organs-on-Chips Model Downstream
Table 128. Human Organs-on-Chips Model Downstream Clients in Global Market
Table 129. Human Organs-on-Chips Model Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Human Organs-on-Chips Model Segment by Type in 2022
Figure 2. Human Organs-on-Chips Model Segment by Application in 2022
Figure 3. Global Human Organs-on-Chips Model Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Human Organs-on-Chips Model Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Human Organs-on-Chips Model Revenue, 2018-2029 (US$, Mn)
Figure 7. Human Organs-on-Chips Model Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Human Organs-on-Chips Model Revenue in 2022
Figure 9. By Type - Global Human Organs-on-Chips Model Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Human Organs-on-Chips Model Revenue Market Share, 2018-2029
Figure 11. By Type - Global Human Organs-on-Chips Model Sales Market Share, 2018-2029
Figure 12. By Type - Global Human Organs-on-Chips Model Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Human Organs-on-Chips Model Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Human Organs-on-Chips Model Revenue Market Share, 2018-2029
Figure 15. By Application - Global Human Organs-on-Chips Model Sales Market Share, 2018-2029
Figure 16. By Application - Global Human Organs-on-Chips Model Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Human Organs-on-Chips Model Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Human Organs-on-Chips Model Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Human Organs-on-Chips Model Revenue Market Share, 2018-2029
Figure 20. By Region - Global Human Organs-on-Chips Model Sales Market Share, 2018-2029
Figure 21. By Country - North America Human Organs-on-Chips Model Revenue Market Share, 2018-2029
Figure 22. By Country - North America Human Organs-on-Chips Model Sales Market Share, 2018-2029
Figure 23. US Human Organs-on-Chips Model Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Human Organs-on-Chips Model Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Human Organs-on-Chips Model Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Human Organs-on-Chips Model Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Human Organs-on-Chips Model Sales Market Share, 2018-2029
Figure 28. Germany Human Organs-on-Chips Model Revenue, (US$, Mn), 2018-2029
Figure 29. France Human Organs-on-Chips Model Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Human Organs-on-Chips Model Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Human Organs-on-Chips Model Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Human Organs-on-Chips Model Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Human Organs-on-Chips Model Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Human Organs-on-Chips Model Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Human Organs-on-Chips Model Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Human Organs-on-Chips Model Sales Market Share, 2018-2029
Figure 37. China Human Organs-on-Chips Model Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Human Organs-on-Chips Model Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Human Organs-on-Chips Model Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Human Organs-on-Chips Model Revenue, (US$, Mn), 2018-2029
Figure 41. India Human Organs-on-Chips Model Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Human Organs-on-Chips Model Revenue Market Share, 2018-2029
Figure 43. By Country - South America Human Organs-on-Chips Model Sales Market Share, 2018-2029
Figure 44. Brazil Human Organs-on-Chips Model Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Human Organs-on-Chips Model Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Human Organs-on-Chips Model Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Human Organs-on-Chips Model Sales Market Share, 2018-2029
Figure 48. Turkey Human Organs-on-Chips Model Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Human Organs-on-Chips Model Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Human Organs-on-Chips Model Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Human Organs-on-Chips Model Revenue, (US$, Mn), 2018-2029
Figure 52. Global Human Organs-on-Chips Model Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Human Organs-on-Chips Model by Region, 2022 VS 2029
Figure 54. Human Organs-on-Chips Model Industry Value Chain
Figure 55. Marketing Channels

※参考情報

ヒト臓器オンチップモデルは、近年のバイオテクノロジーの革新の一環として注目されている技術です。このモデルは、ヒトの臓器や組織の機能をミミックする小型で生体模倣的な構造を持つデバイスで、特に薬物開発や病理学的研究において大きな可能性を秘めています。

このモデルの定義は、微小なチップ上に人間の細胞または組織を配置し、自然の生理的環境を模倣して臓器の機能を再現する技術です。ヒト臓器オンチップは、細胞の種類や配置、さらには流体の流れを調整することで、体内における臓器の動的な反応を再現することが可能です。

ヒト臓器オンチップモデルの特徴の一つは、エレクトロニクスと生物学の統合による高い再現性です。従来の動物実験に比べて、よりリアルなヒトの生理学的条件をシミュレーションすることができ、特に個々の患者の特異的な反応を評価することが可能です。また、チップの設計はカスタマイズ可能であり、特定の研究目的に応じて異なる細胞タイプを使用したり、複数の臓器を連携させたモデルも構築できます。

ヒト臓器オンチップには、主に二つのタイプがあります。一つは単一臓器モデルで、例えば肝臓、心臓、肺など、個々の臓器の機能を独立してシミュレーションします。これにより、特定の臓器における薬物の代謝や毒性試験が行えます。もう一つは多臓器モデルで、複数の臓器を組み合わせて相互作用を模倣することができるモデルです。この多臓器モデルは、病気の進行や薬物の全身への影響を総合的に評価するのに適しています。

用途に関して、ヒト臓器オンチップモデルはさまざまな分野で利用されています。まず第一に、医薬品開発においては、新薬の効果や副作用を評価するための前臨床試験に使用されます。従来の動物実験に比べて、ヒトに即したデータを提供するため、臨床試験での成功率が改善される可能性があります。また、毒性評価や代謝研究にも応用され、化学物質や薬剤の安全性を確保するための有用なツールとなっています。

さらに、病気モデルとしても利用が進んでいます。特に、がんや心疾患、神経疾患など、特定の病態に特化したオンチップモデルは、病理学の理解や新たな治療法の開発に寄与しています。これにより、疾患メカニズムの解明が加速され、個別化医療の実現に向けた進展が期待されています。

関連技術としては、3Dバイオプリンティングやマイクロフルイディクス技術が挙げられます。3Dバイオプリンティングを用いることで、複雑な組織構造を持つモデルの製造が可能となり、より実際の臓器に近い環境を再現できます。マイクロフルイディクス技術は、流体の動きを精密に制御するために必要不可欠で、細胞の環境や相互作用を精緻に調整することができます。

総じて、ヒト臓器オンチップモデルは、従来の研究手法と比較して高い解剖学的および生理学的忠実性を持ち、医療や薬学の進歩に寄与する革新的な技術です。今後もその発展が期待され、医療分野における問題解決に貢献することでしょう。研究者や医療従事者は、この技術を活用することで、より効果的で安全な治療法の開発を目指し、患者にとっての利益を最大化することが求められています。ヒト臓器オンチップモデルは、これからの医療の在り方を変えていく重要なツールであり、その進展は私たちの健康と福祉に対して大きな影響を与えることが予想されます。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ヒト臓器オンチップモデルのグローバル市場展望 2023年-2029年：多臓器モデル、単一臓器モデル、ヒト組織モデル(Human Organs-on-Chips Model Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

ヒト臓器オンチップモデルのグローバル市場展望 2023年-2029年：多臓器モデル、単一臓器モデル、ヒト組織モデル

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp